We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®

News   Feb 17, 2010

 
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
 
 
 

RELATED ARTICLES

Rapid Triage Test Identifies Active Tuberculosis

News

Researchers report in Science Translational Medicine the development of a novel triage test that can rapidly and cheaply identify patients likely to have active tuberculosis (ATB). Use of the test could help detect those needing further diagnostics and treatment, as well as contribute to the improved prevention and control of the disease.

READ MORE

Blood Pressure Drugs Work Best at Bedtime

News

People with high blood pressure who take their anti-hypertensive drugs in one go at bedtime have better controlled blood pressure and a lower risk of death or illness caused by heart or blood vessel problems, compared to people who take their medication in the morning, says new research.

READ MORE

A New Way To “Wrap” Liquid Medication

News

A faster, cheaper way to coat liquid medication has been developed by researchers, an invention that could improve how drugs are delivered in the body.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE